Mesothelioma

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of a relatively fit man with malignant pleural mesothelioma.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of a relatively fit man with malignant pleural mesothelioma.</span></p>  

http://usmlefasttrack.com/?p=6068 Mesothelioma, -, Location,, Characteristics, &, Histology, Findings, symptoms, findings, causes, mnemonics, review, what is...  

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of...  

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same...  

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell...  

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell...  

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according...  

A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos.  

Scientists have identified four biomarkers that may help resolve the difficult differential diagnosis between malignant pleural mesothelioma (MPM) and non-cancerous pleural tissue with...  

A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly...  

Pleural mesothelioma, is an aggressive form of lung cancer strongly linked to asbestos exposure, which has very limited treatment options and is associated with poor patient survival, with most...  

An important survey has launched that will help to inform future research into mesothelioma diagnosis, treatments and care.  

The investigational monoclonal antibody amatuximab (development code: MORAb-009), has been granted orphan drug designation (ODD) for the treatment of malignant mesothelioma by the European...  

Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly...  

Scientists researching one of Britain's deadliest rare cancers, mesothelioma, at...  

For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the...  

The histologic distinction between malignant mesothelioma and reactive mesothelial proliferation can be challenging. Is BAP1 expression useful in the differential diagnosis?  

This report describes a rare example of ectopic ACTH secretion associated with a well-differentiated peritoneal mesothelioma. How was this case distinguished from Cushing's disease?  

A randomized trial shows no extra benefit from adding radiotherapy after surgery and neoadjuvant chemotherapy for mesothelioma.